Serum MBD2, ECP and MPO levels were increased in patients with severe asthma compared to those with asthma (P < 0.001) and HCs (P < 0.001), as well as in patients with asthma compared to HCs (P < 0.001; Figures 2A–C). The gene discussed is MBD2; the disease is asthma.